Liderazgo
Nuestra amplia experiencia, conocimientos empresariales y un objetivo compartido motivan las decisiones diarias para animar a nuestros empleados a alcanzar su máximo potencial.
Mary Duseau
Presidenta
Mary se incorpora a Molecular Devices con más de 25 años de experiencia en el mercado de ciencias de la vida desempeñando funciones de creciente responsabilidad en ventas, marketing y gestión empresarial.
Antes de su incorporación a Molecular Devices, fue vicepresidenta sénior de Gestión Comercial en Leica Biosystems, una empresa de Danaher. Previamente a Danaher, Mary fue CEO y presidenta de Roka Bioscience y antes de esto, vicepresidenta sénior de ventas para Andor Technologies y vicepresidenta global de ventas y marketing para PerkinElmer. Además, en PerkinElmer desempeñó funciones de responsable de la Unidad de Negocios, en adquisición y detección de imágenes, centrada en el mercado del descubrimiento y desarrollo de fármacos.
Es licenciada en Bioquímica por la Universidad de Massachusetts.
Hema Sundarraj
Chief Financial Officer
Hema Sundarraj serves as Chief Financial Officer of Molecular Devices, where she leads the global Finance organization to support strategic execution, accelerate growth, and strengthen financial and operational performance.
Most recently, she was Chief Financial Officer at Phenomenex, a Danaher operating company within the Life Sciences platform. In this role, she drove strong financial results and supported growth initiatives by enhancing working capital management, leading strategic investments, and advancing the company’s IT and eCommerce capabilities. She is also known for building high-performing, engaged teams.
Previously, Hema held senior finance leadership roles at Cepheid, Applied Materials, Nanometrics, Mattson Technology, and Sunpreme. Her experience spans public and private companies, as well as growth-stage organizations.
Hema holds an MBA in Finance and Marketing from XLRI Jamshedpur and is an inactive CPA in the state of California.
Lars Hartvig Kristiansen
Vice President, Product Innovation & Strategy
Lars Hartvig Kristiansen is Vice President of Product Innovation & Strategy, responsible for leading strategic initiatives, driving innovation, and overseeing the global product management team. He leads cross-functional efforts to grow the business through M&A, licensing, and partnerships, while guiding strategic planning and execution across the company.
Lars brings over a decade of experience in life sciences and management consulting. At Agilent Technologies, he held senior roles across strategy, operations, and M&A, including leading strategic growth initiatives for the $4B Life Sciences group and most recently serving as General Manager, running the Global Automation Solutions P&L. He holds Bachelor’s and Master’s degrees in Engineering from Aalborg University, with a focus on Technology Management and Supply Chain.
Dan Green
Vicepresidente de Investigación y Desarrollo
Krishnapal Solanki
Vicepresidente, DBS
Como vicepresidente, DBS, Krishnapal supervisa todos los esfuerzos de mejoras continuas a nivel global en todas las funciones. Krishnapal se unió a Molecular Devices en noviembre de 2021 con más de 13 años de experiencia liderando diferentes funciones en 3 empresas operativas diferentes de Danaher.
La trayectoria de Krishnapal en Danaher comenzó como cliente (investigación en ciencias de la vida) para convertirse posteriormente en asociado de la compañía en Leica Microsystems como ingeniero de servicio de campo sénior, donde desempeñó una serie de funciones progresivas, como supervisor regional de operaciones de servicio de campo, gerente de crecimiento para América, gerente sénior de ventas y marketing de Cepheid y, más recientemente, director de innovación de DBS en Molecular Devices. Krishnapal es experto y ha recibido certificación en las herramientas de mejora de procesos de Danaher como DM/VM, gestión del embudo de ventas y PSP y ha facilitado y dirigido talleres de Kaizen para equipos multifuncionales en varias compañías operadoras de Danaher. Su trabajo como experto incluye la instalación y el mantenimiento de los 3 motores de DBS (Comercial, Innovación y Servicio) para impulsar todo el crecimiento de la organización. Krishnapal también está implicado en actividades de DE&I y ha sido líder de participación de miembros en Asian Descent + Friends ARG en Danaher desde 2021-2022.
Krishnapal cuenta con un máster en Ingeniería Biomédica de UT Arlington y SW Medical Center Dallas. Tiene una licenciatura en ingeniería biomédica de la India.
Lakshmi Sailaja Eleswarapu
Vice President, IT
As Vice President of IT for SCIEX, Molecular Devices, and Danaher Life Sciences, Lakshmi Eleswarapu champions global IT strategy, fostering technological innovation and organizational excellence. Her role extends to supporting the Danaher Life Sciences Innovation Group (LSIG) commercial team and contributing to the L1 team at Molecular Devices. Her tenure includes significant achievements in business transformation, M&A IT integrations, and diversity initiatives. Lakshmi's career spans 26 years in IT, with the last 16 years dedicated to Danaher, positioning her to drive future innovation and growth.
Lakshmi holds a Bachelor’s in Mathematics with Honors from SSSIHL University (India) and a Master’s in Computer Applications from Osmania University (India).
Ray Li
Vice President of Global Operations
Tracy Clarke
Vice President of Service
Tracy Clarke, Vice President of Service, brings over 30 years of experience in the laboratory and medical industry to Molecular Devices. With a remarkable 17-year tenure at Leica Biosystems, Tracy excels in building high-performing teams, managing complex projects, and driving continuous improvement. As Senior Director of Service at Leica, she led a team of 210 professionals, managed a $96M P&L, and consistently drove customer satisfaction and revenue growth. Tracy is committed to enhancing our customers’ experience, building service capabilities, fostering strong cross-functional relationships, and promoting an inclusive culture.
Tracy Clarke, holds a master’s degree in Veterinary Medical Science and a Bachelor’s degree in Molecular Biology & Cell Science from the University of Florida.
Yang Shi
Vice President, Global Commercial
Yang Shi, Ph.D., MBA, is Vice President of Global Commercial at Molecular Devices, where he leads a worldwide team spanning Sales, Field Applications, Customer Service, and Sales Operations. He brings extensive commercial leadership experience from across Danaher, including roles at SCIEX, Phenomenex, and Integrated DNA Technologies (IDT).
Most recently, he served as Vice President of Americas Sales at IDT and previously as Vice President of Global Sales at Phenomenex. Earlier in his career, Yang advanced scientific innovation as a Senior Scientist with Waters Corporation, Thermo Fisher Scientific, and the Sanford Burnham Institute.
Yang holds a Ph.D. in Chemical Engineering from Yale University, an MBA from the University of Massachusetts–Amherst, and B.S. and M.S. degrees in Biochemical Engineering from Tianjin University.